You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 4, April 1931 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

EXPERIMENTAL AND CLINICAL STUDIES OF ERGOTAMINE

IV. THE EFFECT OF ERGOTAMINE ON THE BASAL METABOLISM, CIRCULATION AND BLOOD SUGAR OF NORMAL PERSONS AND OF PATIENTS WITH THYROTOXICOSIS

JOHN B. YOUMANS, M.D.; WILLIAM H. TRIMBLE, M.D.; HELEN FRANK, B.A.

Arch Intern Med. 1931;47(4):612-632.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Ergotamine and the closely related and pharmacologically similar ergotoxin constitute the principal alkaloids of ergot and exhibit all the effects of that drug on the uterus. In addition they have been shown to exert an effect on various parts of the sympathetic nervous system, in particular, a paralyzing or depressing action on the motor elements of that system that are stimulated by epinephrine. Briefly, in animals they not only antagonize the pressor effect of epinephrine on the systemic arteries, but under suitable conditions cause a reversal of the usual effect of epinephrine on the blood pressure.1 Ergotamine inhibits the dilator effect of epinephrine on the coronaries,2 and by its effect on the sympathetic nerves of the heart is said to slow the rate of sinus rhythm3 and to neutralize the accelerator action of epinephrine.4 In addition, ergotamine has been reported both to lower5 and to raise β the blood sugar . . . [Full Text PDF of this Article]


Author Affiliations

With the Technical Assistance of HELEN FRANK, B.A. NASHVILLE, TENN.

NASHVILLE, TENN.

From the Department of Medicine, Vanderbilt University School of Medicine.


Footnotes

Submitted for publication, Aug. 16, 1930.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1931 American Medical Association. All Rights Reserved.